Articles
| Open Access |
Vol. 2 No. 11 (2022): Volume02 Issue11
| DOI:
https://doi.org/10.37547/medical-fmspj-02-11-02
FEATURES OF BIOCHEMICAL INDICATORS IN THE BLOOD IN INFLAMMATORY DISEASES OF THE NOSE AND PARANASAL SINUSES IN PATIENTS WITH MYOCARDITIS
J.А.Djuraev , Researcher Tashkent Medical Academy, Uzbekistan A.Ulugkhudjaeva , Researcher Kimyo International University in Tashkent, Uzbekistan A.Bakhodirova , Researcher Kimyo International University in Tashkent, Uzbekistan E.Akbaraliev , Researcher Kimyo International University in Tashkent, Uzbekistan N.Tolibjonova , Researcher Kimyo International University in Tashkent, Uzbekistan A.Shermatova , Researcher Kimyo International University in Tashkent, Uzbekistan M.Zafarova , Researcher Kimyo International University in Tashkent, Uzbekistan Z.Murodalieva , Researcher Kimyo International University in Tashkent, Uzbekistan F.Abdurasulov , Researcher Kimyo International University in Tashkent, Uzbekistan S.Numonjonova , Researcher Kimyo International University in Tashkent, Uzbekistan M.Mamurjonov , Researcher Kimyo International University in Tashkent, UzbekistanAbstract
It is now known that any of the known pathogens can cause myocardial damage, including myocarditis. Often, viruses that can directly interact with cardiomyocytes become an etiological factor, which leads to cell apoptosis. The authors present the results of a biochemical study of blood in patients with diseases of the nose and paranasal sinuses against the background of myocarditis. It is indicated that the disease of the nose and paranasal sinuses affect the biochemical parameters of the blood and, in turn, exacerbate the course of myocarditis.
Keywords
Myocarditis, blood, nose, paranasal sinuses, LDG
References
Buggey J., ElAmm C.A. Myocarditis and cardiomyopathy. Curr Opin Cardiol. 2018 May;33(3):341-346.
Ghogomu N., Kern R. Chronic rhinosinusitis: the rationale for current treatments. Expert Rev Clin Immunol. 2017 Mar;13(3):259-270.
Hékimian G., Combes A. Myocarditis. Rev Med Interne. 2017 Aug;38(8):531-538.
Mlejnek D., Krejčí J. Myocarditis and inflammatory cardiomyopathy. Vnitr Lek. Fall 2017;63(7-8):507-512.
Romanchuk L., Zoriana O., Anna P. Clinical case of covid-19 complicated with pneumonia, respiratory failure and metabolic cardiomyopathy //The VII International Scientific and Practical Conference «Science, trends and perspectives of development», February 21–23, Budapest, Hungary. 292 p. – С. 117.
Slovick A., Cornet M., Surda P., Tomazic P.V. Chronic rhinosinusitis: New understanding of specific and general Quality of life scores. Rhinology. 2016 Dec 1;54(4):289-291.
Van Linthout S., Tschöpe C. Inflammation - Cause or Consequence of Heart Failure or Both? Curr Heart Fail Rep. 2017 Aug;14(4):251-265.
Vokhidov U. N., Nuriddinov K. N. Some modern features of the distribution and treatment of chronic polyposis rhinosinusitis //Oriental Journal of Medicine and Pharmacology. – 2022. – Т. 2. – №. 01. – С. 131-143.
Vokhidov U.N. State of reticular fibers in various forms of polypoid rhinosinusitis. European science review. 2015(7-8):39-40.
Wu J., Jain R., Douglas R. Effect of paranasal anatomical variants on outcomes in patients with limited and diffuse chronic rhinosinusitis. Auris Nasus Larynx. 2017 Aug;44(4):417-421.
Article Statistics
Downloads
Copyright License
Copyright (c) 2022 J.А.Djuraev, A.Ulugkhudjaeva, A.Bakhodirova, E.Akbaraliev, N.Tolibjonova, A.Shermatova, M.Zafarova, Z.Murodalieva, F.Abdurasulov, S.Numonjonova, M.Mamurjonov
This work is licensed under a Creative Commons Attribution 4.0 International License.